XML 326 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
OPERATING ACTIVITIES      
Net income/(loss) $ 939,057 $ 560,615 $ (167,930)
Net income/(loss) from continuing operations 1,015,507 (64,774) (25,018)
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:      
Depreciation and amortization 51,712 55,362 55,940
Impairment of long-lived assets 76,155 0 0
Net income/(losses) from equity method investments (19,041) (1,080) 537
Change in fair value of investment in listed equity securities (400,966) 295,777 0
INVESTING ACTIVITIES      
Additions to equity method investments (129,662) (6,750)  
FINANCING ACTIVITIES      
Cash and cash equivalents, restricted cash and short-term deposits within assets held for sale at the beginning of period 80,869 65,316 66,988
Cash and cash equivalents, restricted cash and short-term deposits within assets held for sale at the end of period 369 80,869 65,316
Net decrease/(increase) in cash and cash equivalents, restricted cash and short-term deposits within assets held for sale 80,500 (15,553) 1,672
Net increase/(decrease) in cash and cash equivalents, restricted cash, short-term deposits and cash within assets held for sale 674,959 112,366 (117,869)
Cash and cash equivalents, restricted cash and short-term deposits at the beginning of the period 337,922 225,556 343,425
Cash and cash equivalents, restricted cash and short-term deposits at the end of the period 1,012,881 337,922 225,556
Continuing operations      
OPERATING ACTIVITIES      
Net income/(loss) from continuing operations 1,015,507 (64,774) (25,018)
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:      
Depreciation and amortization 51,712 55,362 55,940
Gain on disposal of long lived asset 0 0 (5,682)
Deconsolidation of lessor VIE 0 0 (4,809)
Impairment of long-lived assets 76,155 0 0
Amortization of deferred charges and debt guarantees, net 3,555 1,768 4,870
Net income/(losses) from equity method investments (19,041) (1,080) 537
Compensation cost related to employee stock awards 3,410 2,625 4,482
Net foreign exchange (gain)/losses (1,584) 383 3,106
Change in fair value of investment in listed equity securities (400,966) 295,777 0
Change in fair value of derivative instruments (interest rate swaps) (72,269) (27,016) 46,208
Change in fair value of derivative instruments (oil and gas derivatives), commodity swaps and amortization of day 1 gains 311,585 181,487 (35,150)
Change in assets and liabilities:      
Trade accounts receivable (10,917) (3,083) (7,658)
Inventories (157) 86 (4)
Other current and non-current assets (26,535) (1,495) (19,874)
Amounts due from related parties 367 144 9,285
Trade accounts payable 3,085 (4,648) 1,477
Accrued expenses (4,213) (11,957) (7,941)
Other current and non-current liabilities [1] (27,470) 59,776 (36,413)
Net cash provided by continuing operations 279,054 120,381 53,656
INVESTING ACTIVITIES      
Additions to asset under development (267,421) (213,481) (298,304)
Additions to equity method investments (2,447) (8,625) (10,231)
Proceeds from subscription of equity interest in Gimi MS 39,275 25,403 11,081
Proceeds from sale of equity method investment 97,844 0 0
Proceeds from sale of listed equity securities 625,844 0 0
Dividends received from listed equity securities 5,328 5,029 0
Cash consideration received 0 0 190,131
Short-term loan advanced to related parties 0 (1,750) 0
Net cash provided by/(used in) investing activities 498,423 (193,424) (107,323)
FINANCING ACTIVITIES      
Proceeds from short-term and long-term debt 276,640 411,866 624,901
Repayments of short-term and long-term debt (719,917) (289,148) (745,445)
Net proceeds from the issuance of equity 0 0 99,831
Cash dividends paid (55,169) (33,136) (26,072)
Financing costs paid (9,599) (13,300) (13,300)
Purchase of treasury shares (25,479) (24,484) (16,650)
Proceeds from exercise of share options 161 0 0
Net cash (used in)/provided by financing activities (533,363) 51,798 (76,735)
Supplemental disclosure of cash flow information:      
Interest paid, net of capitalized interest 74,566 35,887 54,004
Income taxes paid 1,465 694 1,181
Discontinued operations      
OPERATING ACTIVITIES      
Net (loss)/income from discontinued operations 76,450 (625,389) 142,912
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:      
Depreciation and amortization 8,732 50,590 51,983
Deconsolidation of lessor VIE (59,085) 0 0
Amortization of deferred charges and debt guarantees, net 3,932 1,280 (981)
Net income/(losses) from equity method investments 0 0 175,988
Compensation cost related to employee stock awards 239 897 938
Net foreign exchange (gain)/losses 571 82 115
Change in assets and liabilities:      
Trade accounts receivable 837 1,836 3,481
Inventories 171 911 (300)
Other current and non-current assets (5,470) 826 4,052
Amounts due from related parties (804) (9,563) 2,348
Trade accounts payable (7,472) 5,598 2,355
Accrued expenses (6,134) 18,147 11,710
Other current and non-current liabilities (24,941) 3,999 (6,029)
Net (loss)/income from discontinued operations (76,450) 625,389 (142,912)
Drydocking expenditure 0 (1,591) (10,622)
Loss/(gain) on disposal and impairment of long-lived assets 105,201 (564,902) 0
Net cash (used in)/provided by discontinued operations (60,673) 133,499 92,126
INVESTING ACTIVITIES      
Additions to equity method investments 0 0 (2,410)
Dividends received from listed equity securities 0 460 10,584
Cash consideration received 569,298 119,535 0
Short-term loan advanced to related parties 0 0 (45,000)
Additions to vessels and equipment 0 (925) (3,880)
Proceeds from repayment of short-term loan advanced to related parties 0 0 45,000
Net cash provided by discontinued investing activities 569,298 119,070 4,294
FINANCING ACTIVITIES      
Proceeds from short-term and long-term debt 0 168,402 104,806
Repayments of short-term and long-term debt (158,000) (268,107) (189,088)
Financing costs paid (280) (3,700) (1,277)
Net cash used in discontinued financing activities $ (158,280) $ (103,405) $ (85,559)
[1] Includes accretion of discount on convertible bonds of $1.7 million, $15.9 million and $15.6 million for the years ended December 31, 2022, 2021 and 2020, respectively.